News & Insights

Press Releases

News

Resources

Webinars

Events

2026-04-16

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

Read more
2026-03-31

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody–Drug Conjugate Development

Read more
2025-11-17

Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards

Read more
2025-10-28

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing

Read more
2025-05-06

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

Read more
2025-04-24

Ajinomoto Co., Inc. to Sell* its Entire Equity Stake in Ajinomoto Althea, a US-based Aseptic Fill/Finish CDMO (*Completed on May 1, 2025)

Read more
2025-03-20

Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards

Read more
2024-09-05

Leading Global CDMO Ajinomoto Bio-Pharma Services Joins CMAC as New Translation to Industry Collaborator

Read more
2024-06-12

Ajinomoto Bio-Pharma Services Announces the Approval of the 32nd Drug Product at their San Diego Sterile Fill Finish Site

Read more
2024-03-12

Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence

Read more
2023-12-27

Notice Regarding Joint Research Agreement with RIBOMIC Inc.

Read more
2023-05-18

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Read more

Loading…Load More

BioPharm International

Contract Biomanufacturing Firms Become More Specialized
Outsourced Pharma

Should You Search Globally For A CMO
GEN

Twists and Turns in Protein Expression
Contract Pharma

Parenteral Outsourcing Trends
Drug Development & Delivery

Prefilled Syringes & Parenteral Contract Manufacturing: Biologics Present a New Set of Challenges
Thermo Fisher Scientific

How to Stand Out from the Biopharmaceutical CMO Crowd
Drug Development & Delivery

Outsourcing Analytical Testing: Innovative Drugs Spike Demand for Advanced Analysis
American Pharmaceutical Review

Biopharmaceuticals/Biosimilars Roundtable

News & Insights

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody–Drug Conjugate Development

Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

Ajinomoto Co., Inc. to Sell* its Entire Equity Stake in Ajinomoto Althea, a US-based Aseptic Fill/Finish CDMO (*Completed on May 1, 2025)

Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards

Leading Global CDMO Ajinomoto Bio-Pharma Services Joins CMAC as New Translation to Industry Collaborator

Ajinomoto Bio-Pharma Services Announces the Approval of the 32nd Drug Product at their San Diego Sterile Fill Finish Site

Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence

Notice Regarding Joint Research Agreement with RIBOMIC Inc.

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Contract Biomanufacturing Firms Become More Specialized

Should You Search Globally For A CMO

Twists and Turns in Protein Expression

Parenteral Outsourcing Trends

Prefilled Syringes & Parenteral Contract Manufacturing: Biologics Present a New Set of Challenges

How to Stand Out from the Biopharmaceutical CMO Crowd

Outsourcing Analytical Testing: Innovative Drugs Spike Demand for Advanced Analysis

Biopharmaceuticals/Biosimilars Roundtable

Ajinomoto Bio-Pharma Services Global Brochure

Containment Excellence in HPAPI Manufacturing: A Lifecycle Approach

HPAPI Containment Excellence: Q&A

S-TuD

Our Platform Technologies and CDMO Capabilities

Oligonucleotide CDMO services overview

miRNA mimic

CpG-ODN (TLR 9 Ligand) reagent

AJICAP Site-Selective Conjugation Technology

Exploring Oligos and Peptides for Pharma Manufacturing

Identify the Production Strategy Best Suited for Your Protein or Peptide

Rethinking Traditional Manufacturing Processes to Identify Green Opportunities